RECURRENT ORAL CAVITY VERRUCOUS CARCINOMA

Clinical trials for RECURRENT ORAL CAVITY VERRUCOUS CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT ORAL CAVITY VERRUCOUS CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT ORAL CAVITY VERRUCOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial tests drug combo in fight against advanced head and neck cancer

Disease control Ongoing

This large, late-stage trial is testing whether adding the drug bevacizumab to standard chemotherapy helps patients with advanced head and neck cancer that has returned or spread. The study enrolled 403 participants to see if the combination helps people live longer or slows canc…

Matched conditions: RECURRENT ORAL CAVITY VERRUCOUS CARCINOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

RECURRENT ORAL CAVITY VERRUCOUS CARCINOMA

Get alerted when new RECURRENT ORAL CAVITY VERRUCOUS CARCINOMA trials appear

Major trial tests drug combo in fight against advanced head and neck cancer